Bianca Santomasso, MD, PhD
Memorial Sloan Kettering Cancer Center
Bianca D. Santomasso, MD, PhD, is an assistant attending neuro-oncologist and scientist at Memorial Sloan Kettering Cancer Center with expertise in the diagnosis and management of neurologic complications of immunotherapies. Dr. Santomasso led the development of Memorial Sloan Kettering protocols for the neurologic monitoring of CAR T cell therapies and was a member of the ASTCT expert panel that developed consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. She serves as a member of the immune related adverse events management guidelines panels for ASCO, NCCN and SITC.
After receiving her undergraduate degree from Yale University, Dr. Santomasso obtained her medical degree from Weill Cornell Medical College and her PhD in immunology from The Rockefeller University. She completed neurology residency at New York-Presbyterian/Weill Cornell Medical Center, followed by a clinical fellowship in neuro-oncology at Memorial Sloan Kettering where she remains on faculty. Dr. Santomasso’s research focuses on understanding mechanisms of toxicity arising from CAR T cell and immune checkpoint blockade treatments with the aim to identify biomarkers and innovative therapeutic approaches to enhance safety and efficacy for patients.